BRIEF-Clovis Oncology says FDA accepts co's new drug application for rucaparib for priority review
August 23, 2016 at 14:43 PM EDT
* FDA accepts Clovis Oncology's new drug application for rucaparib for priority review for the treatment of advanced mutant BRCA ovarian cancer